US/UK/Canada

Share

Pick a time period -
Tags ( Active)

Monivent confirms that the communicated rights issue is 100% secured

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE INCONSISTENT WITH APPLICABLE REGULATIONS OR WOULD REQUIRE REGISTRATION OR SIMILAR ACTIONS. PLEASE REFER TO 'IMPORTANT INFORMATION' AT THE END OF THE PRESS RELEASE. Monivent confirms that the rights issue of approximately 13 MSEK that was decided and communicated on Monday (

Monivent has signed an agreement with Stanford for usability study in the US

Monivent AB announces that the company has signed an agreement with Stanford on behalf of the simulation center CAPE, Center for Advanced Pediatric and Perinatal Education, for the implementation of the planned usability study in the US. The usability study, which is a necessary part of the application for market approval in the US, will be conducted in October to enable finalizing the 510(k) submission to the FDA shortly after that.Conducting a usability study, analyzing how US healthcare professionals interact with the Neo100 system during use in a simulated setting, is what remains

Monivent signs a Letter of Intent (LOI) to enter a global distribution agreement with a major industry leading player

A defining step towards a commercial breakthrough for Monivent’s innovative product (Neo100), supporting a gentle and effective ventilation of newborns, is a strong collaboration with an industry partner with global commercial reach. The signed LOI marks a clear commitment from both parties to negotiate a global distribution and joint product development agreement.As previously communicated, a commercial partnership with one of the market leaders with a matching product portfolio and well-established sales channels has been an integral part of Monivent’s strategy for a successful global

Clinical study using Monivent Neo100 published in Resuscitation

A clinical study showing significant improvement of the quality of manual ventilation of newborns in need of respiratory support using the Neo100 was finalized last year. The clinical paper on the results from this trial has now been accepted to be published in the highly renowned journal Resuscitation and is already available at resuscitationjournal.com. Resuscitation is an international and interdisciplinary medical journal for research relating to acute care medicine and cardiopulmonary resuscitation and recognized by the European Resuscitation Council as its official Journal.The

Irish study shows that Monivent Neo Training improves neonatal resuscitation training

The International Liaison Committee on Resuscitation (ILCOR) has recommended improvements in training for neonatal resuscitation, highlighting the potential role of respiratory function monitors (RFMs). A recent study concluded that standardized training with a simple interface RFM (Neo Training) led to a significant reduction in mask leakage and improvement in all other ventilation parameters. The study has been led by Dr Caitriona M Ni Chathasaigh, The National Maternity Hospital, Dublin and involves a large group of healthcare professionals in maternity and neonatal services.The study "

Monivent Neo100 was associated with superior performance in a study from King’s College London

The study conducted at King’s College London with the use of Neo100, was published in Archives of Disease in Childhood, Fetal and Neonatal Edition. The manikin study demonstrates that the use of a RFM (respiratory function monitor) was associated with superior performance in mask ventilation with the effect being more pronounced in less experienced resuscitators.The results of the study were presented in the publication “Influence of clinical experience on newborn manikin mask ventilation performance using a respiratory function monitor”. The study was conducted to evaluate whether the

Monivent Neo100 purchased by leading medical center in the Netherlands

Monivent has sold the Neo100 to Leiden University Medical Center, LUMC, and the research team lead by Arjan te Pas, Professor in Pediatrics, with specific interest in the perinatal transition and neonatal resuscitation. The research team at LUMC is one of the most experienced centers internationally within the field of respiratory function monitoring and research on neonatal airway management.The research group led by Professor Arjan te Pas at LUMC, home of the Concord resuscitation table, has invested in the Neo100 system. The monitors will be mounted on the Concords, allowing

Clinical study shows that use of Monivent Neo100 significantly increases the quality of ventilation of newborns

The results of a larger clinical study in which Neo100 has been used were presented today at the Pediatric Academic Societies (PAS) annual meeting in Washington. The results showed that the quality of ventilation of newborns who needed respiratory support increased significantly with the use of Monivent's product. Excessive tidal volumes have previously been associated with an increased risk of brain injury and the study showed that high volumes could be reduced when using Neo100."That the results from the study show that using Neo100 significantly can increase the quality of ventilation of

Monivent signs MOU with American Academy of Pediatrics

Monivent AB announces today that the company has signed a Memorandum of Understanding (MOU) together with the American Academy of Pediatrics, AAP, an organization of over 67,000 pediatricians committed to improving the health of all infants and adolescents. This MOU states that the two organizations wish to establish a strategic alliance with the primary purpose of advancing the health and welfare for children and their families and to collaborate in areas of mutual interest that benefits this purpose.As part of the common mission of improving newborn health, one aim is to use Monivent’s

Monivent signs agreement with distributor in Germany

Monivent AB announces today that the company has signed an evaluation agreement with MedCare Visions GmbH for distribution of Monivent Neo Training in Germany.“Having an agreement in place now means that we have the opportunity to reach our potential customers in a much better way in one of our most important key markets. MedCare Visions shares Monivent's vision to improve care for our youngest patients and we look forward to a rewarding and long-term collaboration in the German market, says Karin Dahllöf, CEO of Monivent.” "Our guiding principle, «Our heart beats for the little ones»,

There are no items matching the current filter
There are no more items matching the current filter
Back to top

Subscribe